185 related articles for article (PubMed ID: 29244222)
1. Diffusion-weighted imaging features of breast tumours and the surrounding stroma reflect intrinsic heterogeneous characteristics of molecular subtypes in breast cancer.
Fan M; He T; Zhang P; Cheng H; Zhang J; Gao X; Li L
NMR Biomed; 2018 Feb; 31(2):. PubMed ID: 29244222
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast Cancer.
Fan M; He T; Zhang P; Zhang J; Li L
Sci Rep; 2017 Jun; 7(1):2875. PubMed ID: 28588280
[TBL] [Abstract][Full Text] [Related]
3. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
[TBL] [Abstract][Full Text] [Related]
4. Histogram Analysis and Visual Heterogeneity of Diffusion-Weighted Imaging with Apparent Diffusion Coefficient Mapping in the Prediction of Molecular Subtypes of Invasive Breast Cancers.
Horvat JV; Iyer A; Morris EA; Apte A; Bernard-Davila B; Martinez DF; Leithner D; Sutton OM; Ochoa-Albiztegui RE; Giri D; Pinker K; Thakur SB
Contrast Media Mol Imaging; 2019; 2019():2972189. PubMed ID: 31819738
[TBL] [Abstract][Full Text] [Related]
5. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
[TBL] [Abstract][Full Text] [Related]
6. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
7. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
8. Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.
Incoronato M; Grimaldi AM; Cavaliere C; Inglese M; Mirabelli P; Monti S; Ferbo U; Nicolai E; Soricelli A; Catalano OA; Aiello M; Salvatore M
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1680-1693. PubMed ID: 29696443
[TBL] [Abstract][Full Text] [Related]
9. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.
Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J
J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918
[TBL] [Abstract][Full Text] [Related]
10. Generative adversarial network-based super-resolution of diffusion-weighted imaging: Application to tumour radiomics in breast cancer.
Fan M; Liu Z; Xu M; Wang S; Zeng T; Gao X; Li L
NMR Biomed; 2020 Aug; 33(8):e4345. PubMed ID: 32521567
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy.
Liu S; Ren R; Chen Z; Wang Y; Fan T; Li C; Zhang P
J Magn Reson Imaging; 2015 Sep; 42(3):779-87. PubMed ID: 25580585
[TBL] [Abstract][Full Text] [Related]
12. MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index.
Molinari C; Clauser P; Girometti R; Linda A; Cimino E; Puglisi F; Zuiani C; Bazzocchi M
Radiol Med; 2015 Oct; 120(10):911-8. PubMed ID: 25776017
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
14. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J
Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958
[TBL] [Abstract][Full Text] [Related]
15. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response.
Santamaría G; Bargalló X; Fernández PL; Farrús B; Caparrós X; Velasco M
Radiology; 2017 Jun; 283(3):663-672. PubMed ID: 27875106
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
[TBL] [Abstract][Full Text] [Related]
18. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
Fan M; Li H; Wang S; Zheng B; Zhang J; Li L
PLoS One; 2017; 12(2):e0171683. PubMed ID: 28166261
[TBL] [Abstract][Full Text] [Related]
19. Correlations between diffusion-weighted imaging and breast cancer biomarkers.
Martincich L; Deantoni V; Bertotto I; Redana S; Kubatzki F; Sarotto I; Rossi V; Liotti M; Ponzone R; Aglietta M; Regge D; Montemurro F
Eur Radiol; 2012 Jul; 22(7):1519-28. PubMed ID: 22411304
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors.
Costantini M; Belli P; Distefano D; Bufi E; Matteo MD; Rinaldi P; Giuliani M; Petrone G; Magno S; Bonomo L
Clin Breast Cancer; 2012 Oct; 12(5):331-9. PubMed ID: 23040001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]